Maren Galushko
Overview
Explore the profile of Maren Galushko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Golla H, Ale Ahmad M, Galushko M, Hampl J, Maarouf M, Schroeter M, et al.
Support Care Cancer
. 2014 Aug;
22(12):3341-52.
PMID: 25135840
Purpose: Glioblastoma (GBM) patients have many palliative care (PC) issues. To date, there are no studies examining the prospective usage of validated PC assessment tools as patient reported outcome measures...
12.
Strupp J, Romotzky V, Galushko M, Golla H, Voltz R
J Palliat Med
. 2014 Jul;
17(10):1128-36.
PMID: 25068391
Background: Patients severely affected by multiple sclerosis (MS) present with complex symptoms and needs requiring an interdisciplinary care approach. Objective: Analysis of when and why specialized palliative care integration would...
13.
Strupp J, Golla H, Galushko M, Buecken R, Ernstmann N, Hahn M, et al.
Palliat Support Care
. 2014 May;
13(3):733-40.
PMID: 24849300
Objective: People feeling severely affected by multiple sclerosis (MS) comprise a heterogeneous group, and this heterogeneity leads to very distinct needs and makes planning for needs difficult. To provide optimal...
14.
Galushko M, Strupp J, Walisko-Waniek J, Hahn M, Loffert S, Ernstmann N, et al.
Palliat Support Care
. 2014 May;
13(3):713-23.
PMID: 24849188
Objective: Reliable and validated instruments are needed in order to study the desire for hastened death (DHD). As there is no instrument in the German language to measure DHD, our...
15.
Golla H, Galushko M, Pfaff H, Voltz R
BMC Palliat Care
. 2014 Mar;
13(1):11.
PMID: 24641905
Background: In Germany, patients severely affected by Multiple Sclerosis (MS) do not routinely come into contact with palliative care, even if possibly beneficial. This study was aimed at investigating how...
16.
Galushko M, Golla H, Strupp J, Karbach U, Kaiser C, Ernstmann N, et al.
J Palliat Med
. 2014 Feb;
17(3):274-81.
PMID: 24527993
Background: The needs of patients feeling severely affected by multiple sclerosis (MS) have rarely been investigated. However this is essential information to know before care can be improved, including adding...
17.
Kuhn U, Dusterdiek A, Galushko M, Dose C, Montag T, Ostgathe C, et al.
BMC Res Notes
. 2012 Nov;
5:611.
PMID: 23116368
Background: In Germany, case management in a palliative care unit was first implemented in 2005 at the Department of Palliative Medicine at the University Hospital Cologne. One of the purposes...
18.
Galushko M, Romotzky V, Voltz R
Curr Opin Support Palliat Care
. 2012 Aug;
6(3):355-64.
PMID: 22871981
Purpose Of Review: The purpose of this review is to give an overview of challenges that have been addressed in recent research in end-of-life communication. Recent Findings: Diversity of difficulties...
19.
Buecken R, Galushko M, Golla H, Strupp J, Hahn M, Ernstmann N, et al.
Patient Educ Couns
. 2012 Apr;
88(2):318-24.
PMID: 22480629
Objective: Investigate multiple sclerosis patients' desire to communicate with their physicians about their disease progression and end-of-life issues. Methods: Persons meeting the inclusion criteria of feeling severely affected by MS...
20.
Lindqvist O, Tishelman C, Hagelin C, Clark J, Daud M, Dickman A, et al.
PLoS Med
. 2012 Feb;
9(2):e1001173.
PMID: 22347815
Background: In late-stage palliative cancer care, relief of distress and optimized well-being become primary treatment goals. Great strides have been made in improving and researching pharmacological treatments for symptom relief;...